SNCA and Parkinson disease: However, numerous studies in cell experiments and animal models have confirmed that activation of the NLRP3 inflammasome can also, in turn, lead to increased α-synuclein deposition and diffusion in glial cells, thereby inducing α-synuclein into a positive feedback loop and ultimately promoting PD disease progression.